First pilot newborn screening for four lysosomal storage diseases in an Italian region: Identification and analysis of a putative causative mutation in the GBA gene

Silvia Paciotti, Emanuele Persichetti, Severo Pagliardini, Marta Deganuto, Camillo Rosano, Chiara Balducci, Michela Codini, Mirella Filocamo, Anna Rita Menghini, Veronica Pagliardini, Silvio Pasqui, Bruno Bembi, Andrea Dardis, Tommaso Beccari

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

We report the first newborn screening pilot study in an Italian region for four lysosomal disorders including Pompe disease, Gaucher disease, Fabry disease and mucopolysaccharidosis type 1.The screening has been performed using enzymatic assay on Dry Blood Spot on filter paper. A total of 3403 newborns were screened. One newborn showed a reduction of β-glucosidase activity in leucocytes. Molecular analysis revealed a status of compound heterozygous for the panethnic mutation N370S and for the sequence variation E388K, not yet correlated to Gaucher disease onset. The functional consequences of the E388K replacement on β-glucosidase activity were evaluated by in vitro expression, showing that the mutant protein retained 48% of wild type activity. Structural modeling predicted that the E388K replacement, localized to a surface of the enzyme, would change the local charges distribution which, in the native protein, displays an overwhelming presence of negative charges. However, the newborn, and a 4. year old sister showing the same genomic alterations, are currently asymptomatic.This pilot newborn screening for lysosomal diseases appears to be feasible and affordable to be extended to large populations. Moreover other lysosomal diseases for which a therapy is available or will be available, could be included in the screening.

Original languageEnglish
Pages (from-to)1827-1831
Number of pages5
JournalClinica Chimica Acta
Volume413
Issue number23
DOIs
Publication statusAccepted/In press - Nov 20 2012

Fingerprint

Glucosidases
Lysosomal Storage Diseases
Gaucher Disease
Screening
Genes
Glycogen Storage Disease Type II
Mucopolysaccharidosis I
Fabry Disease
Mutation
Enzyme Assays
Mutant Proteins
Leukocytes
Enzymes
Population
Proteins
Charge distribution
Assays
Blood
Therapeutics
In Vitro Techniques

Keywords

  • α-Glucosidase
  • α-l-Iduronidase
  • Acid α-galactosidase
  • Acid β-glucosidase
  • Lysosomal storage diseases
  • Newborn screening

ASJC Scopus subject areas

  • Biochemistry, medical
  • Clinical Biochemistry
  • Biochemistry
  • Medicine(all)

Cite this

First pilot newborn screening for four lysosomal storage diseases in an Italian region : Identification and analysis of a putative causative mutation in the GBA gene. / Paciotti, Silvia; Persichetti, Emanuele; Pagliardini, Severo; Deganuto, Marta; Rosano, Camillo; Balducci, Chiara; Codini, Michela; Filocamo, Mirella; Menghini, Anna Rita; Pagliardini, Veronica; Pasqui, Silvio; Bembi, Bruno; Dardis, Andrea; Beccari, Tommaso.

In: Clinica Chimica Acta, Vol. 413, No. 23, 20.11.2012, p. 1827-1831.

Research output: Contribution to journalArticle

Paciotti, S, Persichetti, E, Pagliardini, S, Deganuto, M, Rosano, C, Balducci, C, Codini, M, Filocamo, M, Menghini, AR, Pagliardini, V, Pasqui, S, Bembi, B, Dardis, A & Beccari, T 2012, 'First pilot newborn screening for four lysosomal storage diseases in an Italian region: Identification and analysis of a putative causative mutation in the GBA gene', Clinica Chimica Acta, vol. 413, no. 23, pp. 1827-1831. https://doi.org/10.1016/j.cca.2012.07.011
Paciotti, Silvia ; Persichetti, Emanuele ; Pagliardini, Severo ; Deganuto, Marta ; Rosano, Camillo ; Balducci, Chiara ; Codini, Michela ; Filocamo, Mirella ; Menghini, Anna Rita ; Pagliardini, Veronica ; Pasqui, Silvio ; Bembi, Bruno ; Dardis, Andrea ; Beccari, Tommaso. / First pilot newborn screening for four lysosomal storage diseases in an Italian region : Identification and analysis of a putative causative mutation in the GBA gene. In: Clinica Chimica Acta. 2012 ; Vol. 413, No. 23. pp. 1827-1831.
@article{1e709744e64e449abd0ba1dd0f9391dc,
title = "First pilot newborn screening for four lysosomal storage diseases in an Italian region: Identification and analysis of a putative causative mutation in the GBA gene",
abstract = "We report the first newborn screening pilot study in an Italian region for four lysosomal disorders including Pompe disease, Gaucher disease, Fabry disease and mucopolysaccharidosis type 1.The screening has been performed using enzymatic assay on Dry Blood Spot on filter paper. A total of 3403 newborns were screened. One newborn showed a reduction of β-glucosidase activity in leucocytes. Molecular analysis revealed a status of compound heterozygous for the panethnic mutation N370S and for the sequence variation E388K, not yet correlated to Gaucher disease onset. The functional consequences of the E388K replacement on β-glucosidase activity were evaluated by in vitro expression, showing that the mutant protein retained 48{\%} of wild type activity. Structural modeling predicted that the E388K replacement, localized to a surface of the enzyme, would change the local charges distribution which, in the native protein, displays an overwhelming presence of negative charges. However, the newborn, and a 4. year old sister showing the same genomic alterations, are currently asymptomatic.This pilot newborn screening for lysosomal diseases appears to be feasible and affordable to be extended to large populations. Moreover other lysosomal diseases for which a therapy is available or will be available, could be included in the screening.",
keywords = "α-Glucosidase, α-l-Iduronidase, Acid α-galactosidase, Acid β-glucosidase, Lysosomal storage diseases, Newborn screening",
author = "Silvia Paciotti and Emanuele Persichetti and Severo Pagliardini and Marta Deganuto and Camillo Rosano and Chiara Balducci and Michela Codini and Mirella Filocamo and Menghini, {Anna Rita} and Veronica Pagliardini and Silvio Pasqui and Bruno Bembi and Andrea Dardis and Tommaso Beccari",
year = "2012",
month = "11",
day = "20",
doi = "10.1016/j.cca.2012.07.011",
language = "English",
volume = "413",
pages = "1827--1831",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "23",

}

TY - JOUR

T1 - First pilot newborn screening for four lysosomal storage diseases in an Italian region

T2 - Identification and analysis of a putative causative mutation in the GBA gene

AU - Paciotti, Silvia

AU - Persichetti, Emanuele

AU - Pagliardini, Severo

AU - Deganuto, Marta

AU - Rosano, Camillo

AU - Balducci, Chiara

AU - Codini, Michela

AU - Filocamo, Mirella

AU - Menghini, Anna Rita

AU - Pagliardini, Veronica

AU - Pasqui, Silvio

AU - Bembi, Bruno

AU - Dardis, Andrea

AU - Beccari, Tommaso

PY - 2012/11/20

Y1 - 2012/11/20

N2 - We report the first newborn screening pilot study in an Italian region for four lysosomal disorders including Pompe disease, Gaucher disease, Fabry disease and mucopolysaccharidosis type 1.The screening has been performed using enzymatic assay on Dry Blood Spot on filter paper. A total of 3403 newborns were screened. One newborn showed a reduction of β-glucosidase activity in leucocytes. Molecular analysis revealed a status of compound heterozygous for the panethnic mutation N370S and for the sequence variation E388K, not yet correlated to Gaucher disease onset. The functional consequences of the E388K replacement on β-glucosidase activity were evaluated by in vitro expression, showing that the mutant protein retained 48% of wild type activity. Structural modeling predicted that the E388K replacement, localized to a surface of the enzyme, would change the local charges distribution which, in the native protein, displays an overwhelming presence of negative charges. However, the newborn, and a 4. year old sister showing the same genomic alterations, are currently asymptomatic.This pilot newborn screening for lysosomal diseases appears to be feasible and affordable to be extended to large populations. Moreover other lysosomal diseases for which a therapy is available or will be available, could be included in the screening.

AB - We report the first newborn screening pilot study in an Italian region for four lysosomal disorders including Pompe disease, Gaucher disease, Fabry disease and mucopolysaccharidosis type 1.The screening has been performed using enzymatic assay on Dry Blood Spot on filter paper. A total of 3403 newborns were screened. One newborn showed a reduction of β-glucosidase activity in leucocytes. Molecular analysis revealed a status of compound heterozygous for the panethnic mutation N370S and for the sequence variation E388K, not yet correlated to Gaucher disease onset. The functional consequences of the E388K replacement on β-glucosidase activity were evaluated by in vitro expression, showing that the mutant protein retained 48% of wild type activity. Structural modeling predicted that the E388K replacement, localized to a surface of the enzyme, would change the local charges distribution which, in the native protein, displays an overwhelming presence of negative charges. However, the newborn, and a 4. year old sister showing the same genomic alterations, are currently asymptomatic.This pilot newborn screening for lysosomal diseases appears to be feasible and affordable to be extended to large populations. Moreover other lysosomal diseases for which a therapy is available or will be available, could be included in the screening.

KW - α-Glucosidase

KW - α-l-Iduronidase

KW - Acid α-galactosidase

KW - Acid β-glucosidase

KW - Lysosomal storage diseases

KW - Newborn screening

UR - http://www.scopus.com/inward/record.url?scp=84864819731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864819731&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2012.07.011

DO - 10.1016/j.cca.2012.07.011

M3 - Article

C2 - 22820396

AN - SCOPUS:84864819731

VL - 413

SP - 1827

EP - 1831

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 23

ER -